Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ raptor resources limited

Ann: ResApp Enrols First Patient in SMARTCOUGH-C-2 Study, page-16

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 16 Last

Share
Profile

Follow
ryobal

7,161 Posts.

517

08/01/18

15:16

Post #: 30130589
Share

Originally posted by TerribleTadpole ↑

"we now have a world class institute managing" — we had this in the first try as well. The error wasn't in choosing a bad CRO, it was in choosing a CRO with the wrong background and not realising that the difference is important.

"updated algorithms" — they're not updated. The application has a better user interface, and some added validation features to ensure that the collected data is of usable quality. But the algorithm is the same.

On a broader note, I don't expect the current pip to hold. This announcement doesn't really alter the risk profile. There was never any significant risk that the trials wouldn't begin. I believe that significant reduction in risk will be perceived from:

1) release of some good double-blind results, and
2) the first Smartcough-C-2 update if they can release good data quality monitoring results.

I would expect significant and sustained re-rates from each of these events.

Expand

I agree with you that today’s news shouldn’t be that significant. Let’s see how it churns out.
Technically needs to break 9.3c, prev resistance 8.5c so may fall back around that lvl of volume doesn’t get throufh

Last edited by ryobal: 08/01/18

RAP Price at posting: 9.1¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

REA

UK-based Rightmove knocks back REA Group's acquisition proposal

S&P 500 futures dip during non-deciding Trump-Harris Debate; bullish for energy

LU7

Lithium Universe 'dream team' ready to step into the demand-supply breach in Canada

MAY

HotCopper users liking Melbana Energy's news it's becoming an oil producer; shares jump +47%

PIQ

Proteomics ends deal with Sonic Healthcare for US commercialisation of kidney disease test

There are more pages in this discussion • 12 more messages in this thread...

First 16 Last

Add RAP (ASX) to my watchlist